Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care. As the costs of multiple sclerosis (MS) treatments continue to rise, it is ...

With Ocrevus, Genentech did come up with a price that was slightly less than for rival drugs, but only after MS medicines were already extremely expensive. The drug launched last year at an annual ...